Urgent call for time
Urgent call for timely, affordable access to new life-changing epilepsy treatments in Canada
January 10, 2024 07:00 ET | Canadian Epilepsy Alliance
Calgary, AB, Jan. 10, 2024 (GLOBE NEWSWIRE) -- The Canadian Epilepsy Alliance, along with physicians, patients and their families are calling on provincial Health Ministers to address an unmet need...
01_PrimaryLogo_Color_BlueX-100.jpg
Praxis Precision Medicines Provides Update on Advancing Clinical Stage Portfolio
January 08, 2024 08:00 ET | Praxis Precision Medicines, Inc.
Positive preliminary analysis of 15 mg cohort in the PRAX-628 study in epilepsy patients with Photo-Paroxysmal Response (PPR) exceeds expectations; topline results expected in 1Q 2024 after completion...
Catalyst Pharmaceutical logo
Catalyst Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
January 04, 2024 16:49 ET | Catalyst Pharmaceuticals, Inc.
CORAL GABLES, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (“Catalyst” or the “Company”) (Nasdaq: CPRX) announced today that it has commenced an underwritten public...
Crossject engages Sy
Crossject engages Syneos Health for U.S. commercial launch of ZEPIZURE®
January 04, 2024 12:00 ET | CROSSJECT
Press Release Crossject engages Syneos Health for U.S. commercial launch of ZEPIZURE®  Crossject expanding market access activities in preparation for filing for marketing authorization ...
Crossject engage Syn
Crossject engage Syneos Health pour le lancement commercial du ZEPIZURE® aux États-Unis
January 04, 2024 12:00 ET | CROSSJECT
Communiqué de presse Crossject engage Syneos Health pour le lancement commercial du ZEPIZURE® aux États-Unis  Crossject élargit ses activités d'accès au marché dans le cadre des...
Transparency Market Research
Brain Implants Market to Attain a Valuation of USD 8.8 billion by 2031: Transparency Market Research Study
January 04, 2024 04:30 ET | Transparency Market Research
Wilmington, Delaware, United States, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The brain implants market was valued at US$ 4.2 billion in 2022. A CAGR of 8.4% is forecast...
Crossject signs ZEPI
Crossject signs ZEPIZURE® commercialization agreement for northern Europe
December 22, 2023 01:30 ET | CROSSJECT
Crossject to receive up to €1 million on marketing approvals, plus a markup on sales linked to gross margin Agreement, with undisclosed strategic partner, allows Crossject to benefit from strong...
Crossject signe un a
Crossject signe un accord de commercialisation pour ZEPIZURE® en Europe du Nord
December 22, 2023 01:30 ET | CROSSJECT
Crossject recevra jusqu'à 1 million d'euros en vue des approbations de mise sur le marché, plus un multiple des coûts de production lié à la marge brute L'accord, signé avec un partenaire stratégique...
Emergen logo.png
Global Deep Brain Stimulation Market Size to Reach USD 4.27 Billion in 2032 | Emergen Research
December 12, 2023 07:31 ET | Emergen Research
Vancouver, Dec. 12, 2023 (GLOBE NEWSWIRE) -- The global Deep Brain Stimulation (DBS) market, valued at USD 1.70 Billion in 2022, is projected to witness a robust revenue Compound Annual Growth Rate...
Catalyst Pharmaceutical logo
Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2024 List of America's Most Successful Small-Cap Companies
December 05, 2023 08:03 ET | Catalyst Pharmaceuticals, Inc.
CORAL GABLES, Fla., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX) today announced its inclusion in Forbes' esteemed list of America's Most...